Werbung
Deutsche Märkte schließen in 42 Minuten
  • DAX

    18.423,59
    +49,06 (+0,27%)
     
  • Euro Stoxx 50

    4.976,72
    +10,92 (+0,22%)
     
  • Dow Jones 30

    39.308,00
    -23,90 (-0,06%)
     
  • Gold

    2.369,40
    0,00 (0,00%)
     
  • EUR/USD

    1,0810
    +0,0022 (+0,21%)
     
  • Bitcoin EUR

    52.944,72
    -2.781,39 (-4,99%)
     
  • CMC Crypto 200

    1.192,58
    -68,60 (-5,44%)
     
  • Öl (Brent)

    83,69
    -0,19 (-0,23%)
     
  • MDAX

    25.504,01
    +108,74 (+0,43%)
     
  • TecDAX

    3.351,48
    +17,90 (+0,54%)
     
  • SDAX

    14.533,80
    +48,97 (+0,34%)
     
  • Nikkei 225

    40.913,65
    +332,89 (+0,82%)
     
  • FTSE 100

    8.232,53
    +61,41 (+0,75%)
     
  • CAC 40

    7.678,72
    +46,64 (+0,61%)
     
  • Nasdaq Compositive

    18.188,30
    +159,54 (+0,88%)
     

Form 8.3 - Quanex Building Products Corporation

LONDON, July 02, 2024--(BUSINESS WIRE)--

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Quanex Building Products Corporation

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

01-07-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Tyman PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

WERBUNG

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Common Stock

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,096

0.02

28,663

0.09

(2) Cash-settled derivatives:

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

TOTAL:

5,096

0.02

28,663

0.09

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit (USD)

Common Stock

Purchase

1

27.07

Common Stock

Purchase

9

26.64

Common Stock

Purchase

15

26.70

Common Stock

Purchase

15

27.34

Common Stock

Purchase

18

27.26

Common Stock

Purchase

21

27.18

Common Stock

Purchase

22

27.12

Common Stock

Purchase

25

26.52

Common Stock

Purchase

27

26.93

Common Stock

Purchase

29

27.11

Common Stock

Purchase

30

27.07

Common Stock

Purchase

37

26.79

Common Stock

Purchase

42

26.54

Common Stock

Purchase

44

26.99

Common Stock

Purchase

55

26.74

Common Stock

Purchase

69

27.08

Common Stock

Purchase

71

26.97

Common Stock

Purchase

76

27.01

Common Stock

Purchase

80

26.62

Common Stock

Purchase

85

26.69

Common Stock

Purchase

85

27.33

Common Stock

Purchase

89

26.53

Common Stock

Purchase

92

27.16

Common Stock

Purchase

95

26.98

Common Stock

Purchase

100

26.51

Common Stock

Purchase

100

26.86

Common Stock

Purchase

100

26.88

Common Stock

Purchase

100

26.91

Common Stock

Purchase

100

26.94

Common Stock

Purchase

100

27.02

Common Stock

Purchase

100

27.04

Common Stock

Purchase

100

27.06

Common Stock

Purchase

100

27.22

Common Stock

Purchase

100

27.42

Common Stock

Purchase

105

26.92

Common Stock

Purchase

108

26.66

Common Stock

Purchase

116

27.19

Common Stock

Purchase

130

27.15

Common Stock

Purchase

166

27.23

Common Stock

Purchase

184

26.87

Common Stock

Purchase

189

26.78

Common Stock

Purchase

200

26.80

Common Stock

Purchase

200

26.80

Common Stock

Purchase

200

26.91

Common Stock

Purchase

200

26.95

Common Stock

Purchase

200

27.14

Common Stock

Purchase

200

27.21

Common Stock

Purchase

200

27.39

Common Stock

Purchase

200

27.41

Common Stock

Purchase

205

26.88

Common Stock

Purchase

240

26.59

Common Stock

Purchase

263

26.83

Common Stock

Purchase

286

26.55

Common Stock

Purchase

325

27.17

Common Stock

Purchase

328

26.60

Common Stock

Purchase

330

26.77

Common Stock

Purchase

370

26.57

Common Stock

Purchase

386

26.89

Common Stock

Purchase

390

26.82

Common Stock

Purchase

400

26.81

Common Stock

Purchase

410

26.86

Common Stock

Purchase

434

26.61

Common Stock

Purchase

435

26.58

Common Stock

Purchase

467

26.62

Common Stock

Purchase

493

26.90

Common Stock

Purchase

500

26.56

Common Stock

Purchase

531

26.65

Common Stock

Purchase

600

26.67

Common Stock

Purchase

693

26.63

Common Stock

Purchase

768

26.84

Common Stock

Purchase

770

26.64

Common Stock

Purchase

796

26.85

Common Stock

Purchase

6498

26.66

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

02-07-2024

Contact name:

Stuart Brown

Telephone number:

00442070722969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240702170499/en/

Contacts

Qube Research & Technologies LTD